HUREL Products and Services Are Now Part of Visikol
BICO has acquired HUREL micro liver technologies to offer the market's most comprehensive liver in vitro services BICO, leading [...]
BICO has acquired HUREL micro liver technologies to offer the market's most comprehensive liver in vitro services BICO, leading [...]
Autofluorescence has been a recurrent problem in immunofluorescent staining. It impedes on distinguishing specific signaling vs. non-specific (background) in [...]
Join Us for a Free Webinar on Making Precision Cut Tissue Slices for Ex Vivo Assay [...]
Nonalcoholic steatohepatitis (NASH) is a disease of the liver characterized by inflammation, cell injury and fibrosis. Progression of this [...]
BICO launched their new corporate structure focused on pushing the boundaries of science. Watch the brand film below and [...]
We are thrilled to reveal to the world our new logo. Together with the rest of [...]
Understanding the inherent characteristics of cells and their architecture through the selective and differential staining, allows our team to [...]
Dr. Benedict Law’s lab is developing nanomaterials for the more efficient delivery of chemotherapy to cancerous tumors in the [...]
As modern medicine becomes more and more complex, there is a growing need for researchers to understand the body’s [...]
On Tuesday, Visikol's CEO Michael Johnson was named to the 2021 Next Generation of Leaders List by NJBIZ. The [...]